[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100560338":3},{"organization":4,"armGroups":7,"interventions":10,"overallOfficials":10,"centralContacts":12,"locations":18,"responsibleParty":38,"collaborators":10,"id":40,"slug":10,"hasResults":41,"nctId":42,"briefTitle":43,"officialTitle":43,"acronym":10,"eligibilityCriteria":44,"healthyVolunteers":41,"sex":45,"minAge":46,"maxAge":47,"enrollmentInfo":48,"targetDuration":10,"studyType":51,"phases":10,"briefSummary":52,"conditions":53,"keywords":55,"overallStatus":21,"whyStopped":10,"lastUpdateSubmitDate":60,"lastUpdatePostDateStruct":61,"startDateStruct":64,"completionDateStruct":66,"leadSponsor":68,"locationsCount":69},{"fullName":5,"class":6},"University of Colorado, Denver","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":10},"Pediatric patients undergoing anesthesia",null,"Pediatric patients who are undergoing a surgical procedure with anesthesia. Patients will have type 1 diabetes and be wearing a continuous glucose monitor as part of routine care.",[13],{"name":14,"role":15,"phone":16,"phoneExt":10,"email":17},"Erin Cobry, MD","CONTACT","3037242323","Erin.Cobry@cuanschutz.edu",[19],{"facility":20,"status":21,"city":22,"state":23,"zip":24,"country":25,"cosmosGeoPoint":26,"geoPoint":31,"contacts":32},"Barbara Davis Center","RECRUITING","Aurora","Colorado","80045","United States",{"type":27,"coordinates":28},"Point",[29,30],-104.83192,39.72943,{"lat":30,"lon":29},[33,36],{"name":14,"role":15,"phone":34,"phoneExt":10,"email":35},"303-724-2323","erin.cobry@cuanschutz.edu",{"name":14,"role":37,"phone":10,"phoneExt":10,"email":10},"PRINCIPAL_INVESTIGATOR",{"type":39,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR","100560338",false,"NCT06575842","Accuracy of Continuous Glucose Monitors During the Perioperative Period in Youth With Type 1 Diabetes","Inclusion Criteria:\n\n1. Participants will be 2 to 26 years of age at the time of enrollment.\n2. Participants will have a diagnosis of type 1 diabetes on insulin therapy and requiring close glucose monitoring during the hospitalization and the perioperative period.\n3. Participant currently wearing a continuous glucose monitor (for example: Dexcom G6 or G7; Freestyle Libre 2, 2 Plus, or 3; Medtronic Guardian 3 or 4; or future sensors as they become available) for home diabetes management and willing to share personal CGM data with the BDC clinical CGM account.\n\nExclusion Criteria:\n\n1. Pregnancy.\n2. Currently using hydroxyurea.\n3. A condition that the investigator determines would prevent the patient from participation.","ALL","2 Years","26 Years",{"count":49,"type":50},120,"ESTIMATED","OBSERVATIONAL","This study is assessing the accuracy of continuous glucose monitors during surgical procedures requiring anesthesia.",[54],"Type 1 Diabetes",[56,57,58,59],"Anesthesia","Continuous glucose monitors","Accuracy","Pediatrics","2026-06-11",{"date":62,"type":63},"2026-06-12","ACTUAL",{"date":65,"type":63},"2024-08-21",{"date":67,"type":50},"2027-12-01",{"name":5,"class":6},1]